These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30188570)

  • 41. Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review.
    Aggarwal I; Puyana C; Chandan N; Jetter N; Tsoukas M
    Am J Clin Dermatol; 2024 May; 25(3):391-405. PubMed ID: 38351246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contemporary management of actinic keratosis.
    Navarrete-Dechent C; Marghoob AA; Marchetti MA
    J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis.
    Song HS; Jung SE; Jang YH; Kang HY; Lee ES; Kim YC
    Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):296-301. PubMed ID: 26012779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Randomized Trial of Broad Area ALA-PDT for Field Cancerization Mitigation in High-Risk Patients.
    Piacquadio D; Houlihan A; Ferdon MB; Berg JE; Marcus SL
    J Drugs Dermatol; 2020 May; 19(5):452-458. PubMed ID: 32484630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Daylight photodynamic therapy for field cancerization: lessons from molecular biology.
    Rybarski M; Schmitz L; Novak B; Dirschka T
    G Ital Dermatol Venereol; 2018 Dec; 153(6):806-810. PubMed ID: 29683291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Not Available].
    Paugam C; Dréno B
    Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS31-IIS35. PubMed ID: 31133228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis: A Systematic Review and Network Meta-analysis.
    Steeb T; Wessely A; Petzold A; Brinker TJ; Schmitz L; Leiter U; Garbe C; Schöffski O; Berking C; Heppt MV
    JAMA Dermatol; 2021 Sep; 157(9):1066-1077. PubMed ID: 34347015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
    Berman B; Cohen DE; Amini S
    Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
    Fai D; Romano I; Fai C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.
    Steeb T; Heppt MV; Becker L; Kohl C; French LE; Berking C
    Syst Rev; 2019 Oct; 8(1):237. PubMed ID: 31604446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
    Dirschka T; Ekanayake-Bohlig S; Dominicus R; Aschoff R; Herrera-Ceballos E; Botella-Estrada R; Hunfeld A; Kremser M; Schmitz B; Lübbert H; Puig S
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):288-297. PubMed ID: 30022544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Organ transplant recipients need intensive control and treatment of skin cancer].
    Togsverd-Bo K; Sørensen SS; Hædersdal M
    Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
    Dragieva G; Prinz BM; Hafner J; Dummer R; Burg G; Binswanger U; Kempf W
    Br J Dermatol; 2004 Jul; 151(1):196-200. PubMed ID: 15270891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
    Liew YCC; De Souza NNA; Sultana RG; Oh CC
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review.
    Arcuri D; Ramchatesingh B; Lagacé F; Iannattone L; Netchiporouk E; Lefrançois P; Litvinov IV
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PHOTODYNAMIC TREATMENT WITH NANOEMULSIFIED 5-AMINOLEVULINIC ACID AND NARROW BAND RED LIGHT FOR FIELD CANCERIZATION DUE TO OCCUPATIONAL EXPOSURE TO ULTRAVIOLET LIGHT IRRADIATION.
    Wollina U; Gaber B; Koch A
    Georgian Med News; 2018 Jan; (274):138-143. PubMed ID: 29461242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Acta Derm Venereol; 2017 May; 97(5):617-621. PubMed ID: 28093604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.